Sanofi to cut in­sulin prices for unin­sured from $99 to $35, match­ing the in­sulin cap com­ing through Con­gress

As the House-passed bill to cap the month­ly price of in­sulin at $35 na­tion­wide makes its way for a Sen­ate vote soon, Sanofi an­nounced Wednes­day morn­ing that be­gin­ning next month it will cut the month­ly price of its in­sulins for unin­sured Amer­i­cans to $35, down from $99 pre­vi­ous­ly.

The an­nounce­ment from Sanofi, which al­lows the unin­sured to buy one or mul­ti­ple Sanofi in­sulins (Lan­tus, In­sulin Glargine U-100, Tou­jeo, Ad­mel­og, and Apidra) at $35 for a 30-day sup­ply ef­fec­tive Ju­ly 1, fol­lows House pas­sage (232-193) of the month­ly cap in March, with just 12 Re­pub­li­cans vot­ing in fa­vor of the mea­sure.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER